Skip to content
Datasets/NCICCR-DLBCL

Genomic Variation in Diffuse Large B Cell Lymphomas

MixedMachine-extracted
NCICCRAvailable from GDC

Can it answer your research question?

1 of 6 supported
  • Overall survival

    Supported

    Vital status and time are populated; median follow-up 5.1 years; 240 cases with follow-up; endpoint: overall survival.API

  • Progression or recurrence

    Not supported

    progression_or_recurrence is informative for no case in the harmonized records.API

  • Treatment response

    Not supported

    treatment_outcome is populated for no case in the harmonized records.API

  • Which drug was given

    Not supported

    therapeutic_agents is recorded for no case in the harmonized records.API

  • Stage-adjusted modelling

    Not supported

    ajcc_pathologic_stage is informative for no case in the harmonized records.API

  • Analysis by race or ethnicity

    Not supported

    Race is informative for no case in the harmonized records.API

Judged from the repository’s own field completeness (thresholds). “Not measured” means we have not probed that field for this record, not that the data lack it.

At a glance

Every percentage is the repository’s own record of what is filled in
CasesAPI
489
Measurement types
4
5,286 files, 22 TB
Follow-upAPI
5.1 years
for 240 of 489 cases; overall survival
Treatment responseAPI
Not recorded

SubjectCALC

Lymphoid

As filed by the repository

Mature B-Cell LymphomasLymph nodes

Who is in the cohortAPI

A usable value“Not reported” or “unknown”No value recorded
  • Sex288 male · 201 female
  • Race489 not reported
  • Ethnicity489 not reported
  • Vital status388 alive · 101 dead

Age at diagnosis

Median 62, middle half 51–73, range 0–90 years across 489 cases.

What was measured, and on how many

4 measurement types, none covering the whole cohort.

  • Bulk RNA sequencing481 of 489 · 98%
  • Targeted DNA panel sequencing485 of 489 · >99%
  • Whole exome sequencing472 of 489 · 97%
  • Structural Variation481 of 489 · 98%
Platform, files and data levels
AssayPlatformFilesLevels
Bulk RNA sequencingAPIillumina4,329-
Targeted DNA panel sequencingAPIillumina485-
Whole exome sequencingAPIillumina472-
Structural VariationAPI-1,924-
How complete all 29 clinical fields are - 4 informative for at least 80% of cases

A field counts as informative only when it holds a real value. “Not reported” blocks an analysis just as a missing field does. Fields marked 1:n can hold several records per case, so they show the share of cases with any record.

Informative - a usable valuePresent but uninformative - “not reported” or “unknown”Absent - no value recorded

Outcome

  • Vital statusAPI100%
  • Cause of deathAPI0%
  • Progression or recurrenceAPI0%
  • Last known disease statusAPI0%

Follow-up

  • Disease response at follow-upAPI0%
  • Progression at follow-upAPI0%
  • ECOG performance statusAPI0%

Treatment

  • Prior treatmentAPI0%
  • Treatment typeAPI0%
  • Treatment givenAPI0%
  • Therapeutic agentsAPI0%
  • Treatment outcomeAPI0%
  • Regimen or line of therapyAPI0%

Staging

  • AJCC pathologic stageAPI0%
  • AJCC clinical stageAPI0%

Diagnosis

  • Primary diagnosisAPI100%
  • Tissue or organ of originAPI100%
  • Prior malignancyAPI0%
  • Synchronous malignancyAPI0%

Pathology

  • Morphology (ICD-O)API0%
  • Tumor gradeAPI0%
  • Classification of tumorAPI0%

Demographics

  • Sex at birthAPI100%
  • RaceAPI0%
  • EthnicityAPI0%
  • Population groupAPI0%
  • Country of residenceAPI0%

Exposure

  • Tobacco smoking statusAPI0%
  • Alcohol historyAPI0%

Access

MixedSome components are open; others need approval.

Data Access Request through dbGaP using an eRA Commons account; institutional signing official approval required

Open components
481 open-access files
Controlled components
4,805 controlled-access files
Typical turnaround
days to a few weeks after signing official approval
License
NIH Genomic Data Sharing Policy terms
Citation requirement
Cite the dataset accession and the program's publication guidelines; see the GDC publication policy.

What it is good for

Written and checked by a reviewer, not generated from metadata.

No reviewed research questions yet. The measurements and field completeness above are machine-extracted and still useful for judging fit.

What it cannot tell you

Written by a reviewer against the source, not inferred from what is missing.

No reviewed limitations yet. Check the field completeness chart above before committing to an analysis. Low coverage on an endpoint you need is the most common blocker.

Who has used it

Articles that analyzed these data, counted separately from articles that only cited the paper. Only the first counts as reuse.

Analyzed the dataCALC2
24
accession in the methods section
Declared using it
7
named in a data availability statement
Cited the paper
1,833
attention to the publication, not reuse of the data
Against expectation
As expected or above
about 23 articles expected; index 0.05

What articles did with it

Only the last row counts as reuse. Where the accession appears in an article tells us what the authors did with the data.

  • Cited the paper1,833
  • Mentioned the dataset1
  • Accession found in text0
  • Declared using it7
  • Analyzed the data24

Against comparable datasets

24 articles analyzed these data. About 23 would be expected. The expectation comes from a model of size, age, breadth and access tier.

  • Analyzed it24
  • Expected~23
Well known, little used
The publication has 1,833 citations, about 76 for every article that analyzed the data. The finding travelled further than the resource did.
Reuse assessment
  • Reuse is within the expected range for comparable datasets (index +0.05).

Compared against 132 datasets in this corpus with a citable accession and sufficient metadata. See Methods for the model.

Original publication

Articles that analyzed the data

Examples, not the full list. 59 articles matching this dataset's accession search were retrieved and graded individually; these are the strongest of those.

Deep-review sample: author overlap and funding were checked only for the 10 articles listed here, not for every article examined. Of the 10 that analyzed the data, 9 of the 10 we could check had no author in common with the generating team, and 8 of the 10 we could check were themselves NCI-funded. These are sample counts, not population estimates.

Community examples

Share your example

Analyses someone ran on these data end to end, each with a receipt recording when it ran, against which packages and for how long.

Nobody has shared an analysis of this dataset yet. The examples on other datasets cover the common patterns and can be adapted - and if you adapt one, it belongs here.

Start here

Starter code generated from this record’s own identifiers, then the access steps.

Get the data in code

GDC: list open files and download thempython

Open-access files need no account. Controlled files need an approved dbGaP request and a token passed to gdc-client.

import json, requests

PROJECT = "NCICCR-DLBCL"
filters = {"op": "and", "content": [
    {"op": "in", "content": {"field": "cases.project.project_id", "value": [PROJECT]}},
    {"op": "in", "content": {"field": "access", "value": ["open"]}},
]}
params = {"filters": json.dumps(filters),
          "fields": "file_id,file_name,data_category,data_type,file_size",
          "size": "10000", "format": "JSON"}
files = requests.get("https://api.gdc.cancer.gov/files", params=params, timeout=60).json()["data"]["hits"]
print(len(files), "open files")

# Write a manifest and fetch with the GDC client (https://gdc.cancer.gov/access-data/gdc-data-transfer-tool)
with open("manifest.txt", "w") as fh:
    fh.write("id\n" + "\n".join(f["file_id"] for f in files))
# $ gdc-client download -m manifest.txt
GDC: clinical table for every casepython
import json, requests

filters = {"op": "in", "content": {"field": "project.project_id", "value": ["NCICCR-DLBCL"]}}
params = {"filters": json.dumps(filters), "size": "5000", "format": "TSV",
          "fields": ",".join([
              "submitter_id", "demographic.vital_status", "demographic.days_to_death",
              "diagnoses.days_to_last_follow_up", "diagnoses.ajcc_pathologic_stage",
              "diagnoses.treatments.treatment_type", "diagnoses.treatments.treatment_outcome"])}
tsv = requests.get("https://api.gdc.cancer.gov/cases", params=params, timeout=60).text
open("NCICCR-DLBCL_clinical.tsv", "w").write(tsv)
This page as data: limitations firstbash
curl -s https://cd2s.vercel.app/data/datasets/gdc-nciccr-dlbcl.json | python3 -c '
import json, sys
r = json.load(sys.stdin)
for l in r["limitations"]:
    print(l["severity"].upper(), "-", l["statement"][:120])
print("survival endpoint:", r["longitudinal"]["has_survival_endpoint"], "| treatment response:", r["longitudinal"]["has_treatment_response"])'

Access steps

  1. 1
    Open the project in the GDC Data PortalFor people5 minutes

    Check the portal's current case and file counts before requesting anything; the cohort can change after this record was built.

    https://portal.gdc.cancer.gov/projects/NCICCR-DLBCL

    Generated from repository policy. Check the linked policy before downloading.

  2. 2
    Download the open files without an accountFor peopleminutes to hours, by cohort size

    481 open-access files are marked open access. Add them to a portal cart, export a manifest, and fetch it with the GDC Data Transfer Tool.

    gdc-client download -m gdc_manifest.txt
    https://gdc.cancer.gov/access-data/gdc-data-transfer-tool

    Generated from repository policy. Check the linked policy before downloading.

  3. 3
    Request controlled access through dbGaPFor peopledays to a few weeks after signing official approval

    4,805 controlled-access files require an approved data access request. The request starts at dbGaP, not in the portal. The relevant study is phs001444.

    Requires: eRA Commons account, institutional signing official approval, dbGaP data access request for phs001444

    https://gdc.cancer.gov/access-data/obtaining-access-controlled-data

    Generated from repository policy. Check the linked policy before downloading.

  4. 4
    Download controlled files with your tokenFor people

    An approved request yields a token. The same manifest fetches nothing controlled without it.

    Requires: approved dbGaP request, GDC authentication token

    gdc-client download -m gdc_manifest.txt -t gdc-user-token.txt
    https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001444

    Generated from repository policy. Check the linked policy before downloading.

  5. 5
    Query the project from code, with no credentialsFor agents

    The file index is public even where files are not, so an agent can size the cohort before anyone requests access.

    curl -s 'https://api.gdc.cancer.gov/files' --get \
      --data-urlencode 'filters={"op":"in","content":{"field":"cases.project.project_id","value":["NCICCR-DLBCL"]}}' \
      --data-urlencode 'fields=file_id,file_name,data_type' \
      --data-urlencode 'size=10000' --data-urlencode 'format=TSV'
    https://docs.gdc.cancer.gov/API/Users_Guide/Getting_Started/

    Generated from repository policy. Check the linked policy before downloading.

  6. 6
    Pass the token when the agent needs controlled filesFor agents

    Without a token, an API query may return only the open subset. Compare returned counts with the record before treating them as the whole cohort.

    Requires: GDC authentication token

    curl -H "X-Auth-Token: $GDC_TOKEN" https://api.gdc.cancer.gov/data/<file_id>
    https://docs.gdc.cancer.gov/API/Users_Guide/Getting_Started/

    Generated from repository policy. Check the linked policy before downloading.

Provenance

All of it, and more, is in this record’s JSON.

Identifiers

Versions and verification

Released
1 Jan 2018
Metadata retrieved
18 Sept 2026
Review status
Machine-extracted
Data generation funding
Funded data generation

Funding

Awards resolved through NIH RePORTER. Awards that paid to generate these data are listed apart from awards that paid to reuse them. Both are returns on NCI investment, but different ones.

Funded data generation

  • U01CA157581Molecular Diagnosis and Prognosis in Aggressive LymphomaLisa RimszaFY2011-2015API2

Funded reuse of these data

  • R01CA184185Stress Pathways in Tumors Drive Global MDSC Activity and Survival through ChopPaulo Cesar RodriguezFY2015-2019API
  • K23CA201594Breaking immune tolerance to Survivin in Multiple MyelomaFrederick LockeFY2015-2019API
  • R35CA210105From pathogenesis to new therapeutic targets in diffuse large B cell lymphomaRiccardo Dalla-FaveraFY2016-2026API
  • T32CA009566Basic Medical Research Training in OncologyOLUFUNMILAYO F. OLOPADE, Ezra CohenFY1987-2026API
  • R50CA211404Therapeutic insights through patient derived leukemia xenograftsMark WunderlichFY2016-2026API
  • R01CA280389TET2-mediated epitranscriptomic regulation in leukemia microenvironmentJianjun ChenFY2023-2026API
  • R01CA271497The role and therapeutic potential of IGF2BP2 in MLL-rearranged leukemiaJianjun ChenFY2022-2026API
  • R01CA243386Targeting FTO to treat acute myeloid leukemiaJianjun ChenFY2020-2024API
  • R01CA236399The role and mechanism of METTL3/METTL14-mediated RNA modification in the pathogenesis and drug-resistance of AMLJianjun ChenFY2019-2023API
  • R01CA214965The role and mechanism of FTO in leukemogenesis and drug responseJianjun ChenFY2017-2021API

and 1 more

Funded infrastructure or harmonization

  • P30CA076292Immuno-OncologyFrederick Locke, Christine O'ConnellFY1998-2026API
  • P30CA013696Developmental FundsAnil K Rustgi, Andrew B LassmanFY1985-2026API
  • P30CA008748Cancer Center AdministrationALEX MACDONALD, SELWYN M VICKERSFY1985-2026API
  • U01CA305196Mechanism and therapeutic implication of RNA-modification-mediated codon-biased translation in acute myeloid leukemiaJianjun Chen, XIAOLAN DENGFY2025-2026API
  • P30CA033572Leadership, Planning and EvaluationJOHN D. CARPTEN, Alex F. HerreraFY1985-2026API
  • P50CA171963Core A: Biospecimen ProcessingMEAGAN JACOBY, John F. DipersioFY2013-2026API
  • P01CA272295Epigenetic basis and therapeutic targeting of the unique lymphoma immunological nicheLeandro C Cerchietti, CHRISTOPHER R FLOWERSFY2024-2026API
  • P01CA229100Preclinical Models and Therapeutics CoreGiorgio Inghirami, Lisa RimszaFY2018-2022API

For softwarerecord JSON